The Kigali Summit on Malaria and Neglected Tropical Diseases (NTDs)
Hosted by the Rwandan Government, the Kigali Summit gathered governments, pharmaceutical companies, donors,...
Because one-third of the world’s population does not have access to quality healthcare solutions, Sanofi is committed to exploring ways to ensure patients get the treatments they need and improving their quality of life.
As a health journey partner, Sanofi focus on one objective: improving access to healthcare and high-quality medications and vaccines for underserved populations in our fields of expertise by:
Improving access to healthcare requires tackling various barriers. It means innovating to address unmet medical needs and develop new solutions to bring healthcare to patients, ensuring that the conditions are in place in terms of production, supply chain and market access, to make the products and treatments available to patients. It also means building capacity and awareness for stronger healthcare systems. Finally, improving the affordability of products, treatments and related services is also crucial.
In that regard, Sanofi has prioritized three types of activities:
SHOWING 5 of 32 COLLABORATIONS
See AllHosted by the Rwandan Government, the Kigali Summit gathered governments, pharmaceutical companies, donors,...
The Sanofi Global Health Unit (GHU) is a self-sustained nonprofit unit aiming at providing access to...
Signing the Kigali Declaration on NTDs, governments, pharmaceutical companies, donors, and NGOs renewed and...
Global coalition to increase access to essential cancer medicines in low- and lower middle-income countries....
The Rome Action Plan is a compilation of commitments by key stakeholders, including Johnson & Johnson, to...
SHOWING 5 of 32 COLLABORATIONS
See All